Natural compound histone deacetylase inhibitors (HDACi): Synergy with inflammatory signaling pathway modulators and clinical applications in cancer

Medicine and Dentistry

• Malignant Neoplasm 100%
• Histone Deacetylase Inhibitor 100%
• Cell Signaling Pathway 100%
• Natural Product 100%
• Neoplasm 66%
• Angiogenesis 33%
• Cancer Cell 33%
• Tumor Cell 33%
• Metastatic Carcinoma 33%
• Genomic Instability 33%
• Transcription Factors 33%
• Cell Death 33%
• Multifactorial Disease 33%
• Cell Energy 33%

Biochemistry, Genetics and Molecular Biology

• Histone Deacetylase 100%
• Genome Instability 50%
• Multifactorial Disease 50%
• Cancer Cell 50%
• Angiogenesis 50%
• Transcription Factors 50%
• Cell Death 50%
• Cell Energy 50%

Keyphrases

• Inflammatory Transcription Factors 50%
• Tumor Inflammation 50%
• Combination Treatment Strategy 50%
• Growth Suppressor 50%
• Proliferative Signaling 50%
• Replicative Immortality 50%
• Cellular Energetics 50%